Brands: Ativan · Lorazepam
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | generic | 13 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 2 | SUPPLYING |
| Civica, Inc | unknown | 1 | SUPPLYING |
| International Medication Systems, Limited | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds — Recalling firm: Hikma Pharmaceuticals USA Inc. — Distributed Nationwide in the USA
Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA and Puerto Rico
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples. — Recalling firm: Hikma Pharmaceuticals USA Inc. — Nationwide in the USA
Lorazepam Injection — reported in shortage by Amphastar Pharmaceuticals, Inc.. Therapeutic category: Neurology.
Lorazepam Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Neurology.
Lorazepam Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.
